Clinical Validation Studies

About I-Tech Medical Division

I-Tech Medical Division, a brand of IACER Srl, is a private Italian manufacturer of certified electromedical devices for pain and rehabilitation, emphasizing decentralized, home-based care. Founded in 2008, the company has grown under the leadership of Massimo Marcon and Matteo Zennaro, leveraging a portfolio of clinically validated technologies. It operates with a team of over 80 people and supports healthcare professionals with training and clinical studies. The company is navigating the shift towards digital and home therapy, with its devices now compliant with the EU's Medical Device Regulation (MDR).

About Prostatype Genomics

Prostatype Genomics is a commercial-stage diagnostics company addressing the critical unmet need for accurate risk stratification in prostate cancer. Its core achievement is the development and commercialization of the Prostatype® test, a validated prognostic tool that integrates a proprietary 3-gene signature with standard clinical parameters to predict prostate cancer-specific mortality. The company's strategy is to drive clinical adoption in Europe and secure regulatory clearance and reimbursement in the massive US market, leveraging a seasoned management team with deep diagnostics and urology expertise. Prostatype aims to become a standard-of-care tool to personalize treatment, improve patient outcomes, and generate cost savings for healthcare systems.

Therapeutic Areas